Envoy Medical (NASDAQ:COCH – Get Free Report) is projected to announce its earnings results before the market opens on Monday, April 7th. Analysts expect the company to announce earnings of ($0.33) per share for the quarter.
Envoy Medical (NASDAQ:COCH – Get Free Report) last released its earnings results on Friday, March 28th. The company reported ($0.45) EPS for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.12). The firm had revenue of $0.04 million during the quarter, compared to the consensus estimate of $0.07 million. On average, analysts expect Envoy Medical to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Envoy Medical Stock Performance
COCH opened at $1.38 on Friday. Envoy Medical has a fifty-two week low of $1.21 and a fifty-two week high of $7.10. The firm has a 50-day moving average of $1.45 and a 200 day moving average of $1.95. The firm has a market cap of $27.84 million, a P/E ratio of -0.98 and a beta of 2.35.
About Envoy Medical
Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.
Featured Articles
- Five stocks we like better than Envoy Medical
- How to Profit From Growth Investing
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- The How And Why of Investing in Oil Stocks
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Earnings Per Share Calculator: How to Calculate EPS
- Spotify Stock Eyes Double-Digit UpsideāIs Now the Time to Buy?
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.